Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
It is the first branded generic alternative to Fostair 100/6 pMDI
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Lutio has the potential to offer significant cost savings when available to UK patients.
Subscribe To Our Newsletter & Stay Updated
